BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2075830)

  • 1. Successful chemotherapy on a pregnant non-Hodgkin's lymphoma patient.
    Toki H; Okabe K; Kamei H; Shimokawa T; Hiura M; Kondo M; Hirota Y
    Acta Med Okayama; 1990 Dec; 44(6):321-3. PubMed ID: 2075830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hodgkin's lymphoma in pregnancy.
    Garg A; Kochupillai V
    South Med J; 1985 Oct; 78(10):1263-4. PubMed ID: 3840280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disseminated, highly malignant non-Hodgkin's lymphoma and pregnancy: polychemotherapy in the 2d and 3d trimester].
    du Bois A; Runge M; Schmid J; Hillemanns HG
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):405-9. PubMed ID: 2373337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient.
    Goldwasser F; Pico JL; Cerrina J; Fernandez H; Pons JC; Cosset JM; Hayat M
    Leuk Lymphoma; 1995 Dec; 20(1-2):173-6. PubMed ID: 8750642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive primary thyroid non Hodgkin's lymphoma with pregnancy.
    Soliman KB; Abbas MM; Seksaka MA; Wafa S; Balah AS
    Saudi Med J; 2007 Apr; 28(4):634-6. PubMed ID: 17457494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in non-Hodgkin's lymphoma during pregnancy.
    Lambert J; Wijermans PW; Dekker GA; Ossenkoppele GJ
    Neth J Med; 1991 Feb; 38(1-2):80-5. PubMed ID: 2030816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective comparison between CHOP-PVP and CHOP protocols for non-Hodgkin's lymphoma.
    Gan H; Zhang F; Lin Y
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):397-9. PubMed ID: 12408775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VACOP-B chemotherapy for high grade non-Hodgkin's lymphoma in pregnancy.
    Rodriguez JM; Haggag M
    Clin Oncol (R Coll Radiol); 1995; 7(5):319-20. PubMed ID: 8580059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
    Yuan ZY; Xu RH; He YJ; Guan ZZ
    Ai Zheng; 2003 Apr; 22(4):393-6. PubMed ID: 12703996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
    Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
    N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
    Bernard M; Cartron G; Rachieru P; LeMevel A; Branger B; Le Maignan C; Berthou C; Ghandour C; Delwail V; Milpied N; Cassasus P; Celigny PS; Guyotat D; Lamy T; Desablens B;
    Haematologica; 2005 Jun; 90(6):802-9. PubMed ID: 15951293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice].
    van Agthoven M; Wittebol S; Budel LM; Uyl-de Groot CA; Kramer MH
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):88-93. PubMed ID: 14753131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated primary non-Hodgkin's malignant lymphoma of the larynx.
    Cavalot AL; Preti G; Vione N; Nazionale G; Palonta F; Fadda GL
    J Laryngol Otol; 2001 Apr; 115(4):324-6. PubMed ID: 11276342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
    Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
    Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful treatment with preceding low-intensity chemotherapy in a primary mediastinal large B cell lymphoma patient diagnosed at 11 weeks of pregnancy].
    Hattori D; Yahagi Y; Uryu H; Hosoba R; Momoki M; Nagao R; Yamazaki H
    Rinsho Ketsueki; 2019; 60(2):112-117. PubMed ID: 30842377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen].
    Huang HQ; Jiang WQ; Wang W; Zhou ZM; Xia ZJ; Lin XB; Li YH; Xu RH; Zhang L; Xu GC; Sun XF; Liu DG; He YJ; Guan ZZ
    Ai Zheng; 2003 Apr; 22(4):389-92. PubMed ID: 12703995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.
    Singla R; Kumar P; Bahl A; Kumar S; Saran RK; Kar P
    Trop Gastroenterol; 2008; 29(4):227-8. PubMed ID: 19323094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
    Alliot C
    J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.